Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

What Awaits ZIM Integrated Shipping (ZIM) in Q2 Earnings?

Published 08/11/2021, 01:07 AM
Updated 07/09/2023, 06:31 AM

ZIM Integrated Shipping Services ZIM is scheduled to report second-quarter 2021 results on Aug 18, before market open.

The Zacks Consensus Estimate for second-quarter earnings has been stable at $5.71 per share over the past 60 days. The consensus mark for revenues is currently pegged at $1.91 billion.

Against this backdrop, let’s take a look at the factors that might have shaped the company’s June-quarter performance.

With the gradual resumption of economic activities, the world trade picked up the pace, which in turn, is likely to aid the second-quarter results of shipping stocks like ZIM Integrated Shipping. This is because the shipping industry is responsible for transporting an enormous proportion of goods involved in world trade. Revenues in the to-be-reported quarter are expected to have increased sequentially, driven by improved revenues from containerized cargo, reflecting higher freight rates among other factors.

Bullishness surrounding the containership market is a huge positive for ZIM Integrated Shipping and might have boosted its top line in the soon-to-be-reported quarter. The containership market is being aided by ramped-up manufacturing activities in Asia besides other factors. The already steep container rates were further hiked by the Suez Canal crisis earlier this year.

On the flip side, escalated voyage operating expenses, mainly due to increased fuel costs, are likely to have hurt the bottom line in the June quarter.

Earnings Whispers

Our proven model does not predict an earnings beat for ZIM Integrated Shipping this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of a positive surprise. However, that is not the case here. You can see the complete list of today’s Zacks #1 Rank stocks here.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Earnings ESP: ZIM Integrated Shipping has an Earnings ESP of 0.00% as the Most Accurate Estimate is in line with the Zacks Consensus Estimate. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.

Zacks Rank: ZIM Integrated Shipping has a Zacks Rank #3, currently.

Highlights of Q1 Earnings

ZIM Integrated Shipping’s first-quarter earnings of $5.13 per share surpassed the Zacks Consensus Estimate of $4.09. Total revenues of $1,744.3 million also surpassed the Zacks Consensus Estimate of $1,533.5 million.

Sectorial Snapshots

Let’s look into some of the other recently released earnings reports from companies within the Zacks Transportation sector.

Knight-Swift Transportation Holdings KNX, presently carrying a Zacks Rank #2, reported second-quarter 2021 earnings (excluding 6 cents from non-recurring items) of 98 cents per share, surpassing the Zacks Consensus Estimate of 87 cents. Total revenues of $1,315.7 million also outperformed the Zacks Consensus Estimate of $1,300.8 million.

SkyWest (NASDAQ:SKYW) SKYW, currently flaunting a Zacks Rank of 1, reported second-quarter 2021 earnings of $1.22 per share, beating the Zacks Consensus Estimate of 28 cents. Quarterly earnings also came against the year-ago loss per share of 51 cents. Revenues in the June quarter summed $657 million, not only surpassing the Zacks Consensus Estimate of $581.5 million but also increasing 87.7% year over year.

United Parcel Service (NYSE:UPS) UPS, currently carrying a Zacks Rank of 3, reported second-quarter 2021 earnings (excluding a penny from non-recurring items) of $3.06 per share, beating the Zacks Consensus Estimate of $2.75. Quarterly revenues of $23,424 million also outperformed the Zacks Consensus Estimate of $23,085.4 million.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

United Parcel Service, Inc. (UPS): Free Stock Analysis Report

KnightSwift Transportation Holdings Inc. (KNX): Free Stock Analysis Report

SkyWest, Inc. (SKYW): Free Stock Analysis Report

ZIM Integrated Shipping Services Ltd. (ZIM): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.